A novel monoclonal antibody, 1B3.1, binds to a new epitope of the VLA-1 molecule

Ilan Bank*, Martin Hemler, Michael B. Brenner, Dina Cohen, Vered Levy, Jonathan Belko, Carol Crouse, Leonard Chess

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

A monoclonal antibody, 1B3.1, was raised against a cloned IL-2-dependent T cell line that expresses the TγδT cell receptor. MoAb 1B3.1 reacted with long-term cultured T cell lines of both Tγδ and Tαβ lineage, and with in vivo-stimulated T cells, derived from synovial fluid, but not with resting or short-term activated T cells, B cells, or macrophages. Immunoprecipitation of the 1B3.1 target antigens showed that 1B3.1 recognizes a 200/110 kDa molecule that is identical to the VLA-1 heterodimer precipitated by MoAb TS2/7. 1B3.1, however, binds to an epitope of VLA-1 that is distinct from the TS2/7 binding site. This new MoAb could be useful in further studies of the functions of VLA-1, and of the cells that express this molecule.

Original languageEnglish
Pages (from-to)416-423
Number of pages8
JournalCellular Immunology
Volume122
Issue number2
DOIs
StatePublished - Sep 1989

Funding

FundersFunder number
IsraelC ancerR esearchF oundationF
United States-IsraelB inational Science Foundation
National Institutes of Health
National Cancer InstituteR01CA042368
United States-Israel Binational Science Foundation

    Fingerprint

    Dive into the research topics of 'A novel monoclonal antibody, 1B3.1, binds to a new epitope of the VLA-1 molecule'. Together they form a unique fingerprint.

    Cite this